Defecetive Drugs: adrugrecall.com
NEWSLETTER
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Baycol class action approved in Canada
-December 15, 2004
The Ontario Superior Court of Justice and the Quebec Superior Court have approved a settlement, which has certified classes of Baycol users who suffered from rhabdomyolysis, a severe muscle disease.
Baycol was a cholesterol-lowering drug that was withdrawn from the Canadian market in August 2001 after reports of rhabdomyolysis were made. The Baycol class action lawsuit represents users suffering from rhabdomyolysis outside of British Columbia. The settlement was reached without any admission of liability from Bayer.
For more information on Baycol, please contact us.
